Skip to main content

CVS HEALTH Corp

For the period ended Dec 31, 2025. Filed Feb 10, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 10, 2026

CVS$85.25+1.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

CVS HEALTH CORPORATION
Date:February 10, 2026By:/s/ BRIAN O. NEWMAN
Brian O. Newman
Executive Vice President and Chief Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitle(s)Date
/s/ FERNANDO AGUIRREDirectorFebruary 10, 2026
Fernando Aguirre
/s/ JEFFREY R. BALSER, M.D., Ph.D.DirectorFebruary 10, 2026
Jeffrey R. Balser, M.D., Ph.D.
/s/ C. DAVID BROWN IIDirectorFebruary 10, 2026
C. David Brown II
/s/ JAMES D. CLARKSenior Vice President - Controller and ChiefFebruary 10, 2026
James D. ClarkAccounting Officer (Principal Accounting Officer)
/s/ ALECIA A. DECOUDREAUXDirectorFebruary 10, 2026
Alecia A. DeCoudreaux
/s/ ROGER N. FARAHDirectorFebruary 10, 2026
Roger N. Farah
/s/ ANNE M. FINUCANEDirectorFebruary 10, 2026
Anne M. Finucane
/s/ J. DAVID JOYNERPresident, Chief Executive Officer (Principal ExecutiveFebruary 10, 2026
J. David JoynerOfficer), Chair of the Board and Director
/s/ J. SCOTT KIRBYDirectorFebruary 10, 2026
J. Scott Kirby
/s/ MICHAEL F. MAHONEYDirectorFebruary 10, 2026
Michael F. Mahoney
/s/ BRIAN O. NEWMANExecutive Vice President and Chief Financial OfficerFebruary 10, 2026
Brian O. Newman(Principal Financial Officer)
/s/ LESLIE V. NORWALKDirectorFebruary 10, 2026
Leslie V. Norwalk
/s/ LARRY M. ROBBINSDirectorFebruary 10, 2026
Larry M. Robbins
/s/ GUY P. SANSONEDirectorFebruary 10, 2026
Guy P. Sansone
/s/ DOUGLAS H. SHULMANDirectorFebruary 10, 2026
Douglas H. Shulman
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.